BNC Wealth Management LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

BNC Wealth Management LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,148 shares of the medical equipment provider’s stock after buying an additional 603 shares during the quarter. Intuitive Surgical makes up about 1.9% of BNC Wealth Management LLC’s portfolio, making the stock its 15th biggest position. BNC Wealth Management LLC’s holdings in Intuitive Surgical were worth $5,819,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $36,000. Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $38,000. Finally, DT Investment Partners LLC raised its stake in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ISRG shares. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Raymond James increased their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $592.64 on Friday. The company has a market capitalization of $211.09 billion, a PE ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. The company has a 50 day simple moving average of $540.66 and a two-hundred day simple moving average of $498.77. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 in the last ninety days. Company insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.